Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma
Akiko Eguchi, Hiroshi Hasegawa, Motoh Iwasa, Yasuyuki Tamai, Keiichi Ohata, Tsuyoshi Oikawa, Takeshi Sugaya, Yoshiyuki Takei – 2 April 2019 – Liver‐type fatty acid–binding protein (L‐FABP) is a key regulator of fatty acid metabolism, but serum L‐FABP levels are not well investigated in chronic liver diseases. We aimed to elucidate the prognostic ability of serum L‐FABP in human chronic liver diseases and compare it with the albumin‐bilirubin (ALBI) score.